Anti-LGALSL Rabbit Polyclonal Antibody for WB and ELISA - Q3ZCW2

Core Product Specifications and Parameters

Biological Background: Galectin-Related Protein (LGALSL) Function and Localization

• Galectin-related protein (LGALSL), also known as galectin-like protein or lectin galactoside-binding-like protein, is a distinct member of the galectin family with a predicted non‑carbohydrate‑binding profile.
• Unlike typical galectins, LGALSL does not bind lactose and may not interact with carbohydrates, suggesting an alternative functional role in cellular processes.
• The protein is post‑translationally modified by acetylation and phosphorylation, which could modulate its activity or localization.
• Its 3D structure has been solved, providing insight into its molecular configuration (Keyword: 3D‑structure).
• LGALSL has been detected in proteomic screens, confirming its expression in human tissues (Reference proteome).

Experimental Guidance and Technical Tips

• The immunogen used is a recombinant fusion protein covering amino acids 1–172 of human LGALSL (NP_054900.2). This full‑length antigen design supports recognition of the native protein.
• For Western blotting (WB), consider using whole‑cell lysates from human or mouse samples, as cross‑reactivity with the mouse ortholog has been experimentally observed.
• In ELISA applications, validate antibody performance with recombinant LGALSL or appropriate tissue lysates, and include appropriate controls to confirm specificity.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio is your dedicated partner for one‑stop IVD raw‑material sourcing, assisting diagnostic manufacturers and research laboratories from early‑stage development through to clinical application. This anti‑LGALSL polyclonal antibody addresses the growing interest in non‑canonical lectins and galectin family biology. CamelBio supplies validated antibody pairs, optimized monoclonal/polyclonal antibodies, and bulk ancillary reagents—along with sourcing capabilities for rare target raw materials—all backed by comprehensive technical consultation.